Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Gandara

Showing results (1-10 of 322) with videos related to

Pageof 33
Sort By:
Clinical Advances in Hematology & Oncology : H&O|November 1, 2005
Developing targeted therapies for lung cancerDavid R Gandara
Clinical Lung Cancer|April 28, 2006
Bronchioloalveolar carcinoma: the "changing face of lung cancer"David R Gandara
Clinical Lung Cancer|December 16, 2005
Treatment options for patients with advanced-stage non-small-cell lung cancer: who are the "elderly" and who are the "unfit"?David R Gandara, Paul Hesketh
Clinical Lung Cancer|July 28, 2009
A decade of clinical lung cancerDavid R Gandara, Jasper Simons
The Lancet. Oncology|June 21, 2013
FASTACT-2: but don't act too fastFred R Hirsch, David R Gandara
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 27, 2005
Epidermal growth factor receptor tyrosine kinase inhibitors plus chemotherapy: case closed or is the jury still out?David R Gandara, Paul H Gumerlock
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 10, 2006
Oral second-line chemotherapy for advanced non-small-cell lung cancer: the bottom lineDavid R Gandara, Angela M Davies
Journal for Immunotherapy of Cancer|July 7, 2025
Authors response to "Letter to the Editor": "Tumor mutational burden and survival on immune checkpoint inhibition in >8000 patients across 24 cancer types"Ryon P Graf, David R Gandara
Clinical Lung Cancer|July 3, 2017
An Evolving Algorithm to Select and Sequence Therapies in EGFR Mutation-positive NSCLC: A Strategic ApproachBarbara Melosky, Sanjay Popat, David R Gandara
Clinical Lung Cancer|April 21, 2021
Novel Clinical Trial Designs in Pursuit of Precision Oncology: Lung-MAP As a ModelJonathan W Riess, Christian Rolfo, David R Gandara
Pageof 33

Showing results (1-10 of 322) with videos related to

Sort By:
Pageof 33
Clinical Advances in Hematology & Oncology : H&O|November 1, 2005
Developing targeted therapies for lung cancerDavid R Gandara
Clinical Lung Cancer|April 28, 2006
Bronchioloalveolar carcinoma: the "changing face of lung cancer"David R Gandara
Clinical Lung Cancer|December 16, 2005
Treatment options for patients with advanced-stage non-small-cell lung cancer: who are the "elderly" and who are the "unfit"?David R Gandara, Paul Hesketh
Clinical Lung Cancer|July 28, 2009
A decade of clinical lung cancerDavid R Gandara, Jasper Simons
The Lancet. Oncology|June 21, 2013
FASTACT-2: but don't act too fastFred R Hirsch, David R Gandara
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 27, 2005
Epidermal growth factor receptor tyrosine kinase inhibitors plus chemotherapy: case closed or is the jury still out?David R Gandara, Paul H Gumerlock
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 10, 2006
Oral second-line chemotherapy for advanced non-small-cell lung cancer: the bottom lineDavid R Gandara, Angela M Davies
Journal for Immunotherapy of Cancer|July 7, 2025
Authors response to "Letter to the Editor": "Tumor mutational burden and survival on immune checkpoint inhibition in >8000 patients across 24 cancer types"Ryon P Graf, David R Gandara
Clinical Lung Cancer|July 3, 2017
An Evolving Algorithm to Select and Sequence Therapies in EGFR Mutation-positive NSCLC: A Strategic ApproachBarbara Melosky, Sanjay Popat, David R Gandara
Clinical Lung Cancer|April 21, 2021
Novel Clinical Trial Designs in Pursuit of Precision Oncology: Lung-MAP As a ModelJonathan W Riess, Christian Rolfo, David R Gandara
Pageof 33